These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37607440)

  • 1. The application of PROTAC in HDAC.
    Chen S; Zheng Y; Liang B; Yin Y; Yao J; Wang Q; Liu Y; Neamati N
    Eur J Med Chem; 2023 Nov; 260():115746. PubMed ID: 37607440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HaloTag-Targeted Sirtuin-Rearranging Ligand (SirReal) for the Development of Proteolysis-Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)*.
    Schiedel M; Lehotzky A; Szunyogh S; Oláh J; Hammelmann S; Wössner N; Robaa D; Einsle O; Sippl W; Ovádi J; Jung M
    Chembiochem; 2020 Dec; 21(23):3371-3376. PubMed ID: 32672888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing HDAC-PROTACs: lessons learned so far.
    Fischer F; Alves Avelar LA; Murray L; Kurz T
    Future Med Chem; 2022 Jan; 14(3):143-166. PubMed ID: 34951318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the Design and Development of PROTAC-mediated HDAC Degradation.
    Rodrigues DA; Roe A; Griffith D; Chonghaile TN
    Curr Top Med Chem; 2022 Mar; 22(5):408-424. PubMed ID: 34649488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-Specific Degradation of Histone Deacetylase Using Warhead-Caged Proteolysis Targeting Chimeras.
    Jia Q; Zhang Y; Liu F; Dong W; Zhu L; Wang F; Jiang JH
    Anal Chem; 2023 Nov; 95(45):16474-16480. PubMed ID: 37903331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC).
    Cao F; de Weerd S; Chen D; Zwinderman MRH; van der Wouden PE; Dekker FJ
    Eur J Med Chem; 2020 Dec; 208():112800. PubMed ID: 32971411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing class I histone deacetylases (HDAC) with proteolysis targeting chimera (PROTAC) for the development of highly potent and selective degraders.
    Ibrahim HS; Guo M; Hilscher S; Erdmann F; Schmidt M; Schutkowski M; Sheng C; Sippl W
    Bioorg Chem; 2024 Oct; 153():107887. PubMed ID: 39423771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-Phase Synthesis of Cereblon-Recruiting Selective Histone Deacetylase 6 Degraders (HDAC6 PROTACs) with Antileukemic Activity.
    Sinatra L; Yang J; Schliehe-Diecks J; Dienstbier N; Vogt M; Gebing P; Bachmann LM; Sönnichsen M; Lenz T; Stühler K; Schöler A; Borkhardt A; Bhatia S; Hansen FK
    J Med Chem; 2022 Dec; 65(24):16860-16878. PubMed ID: 36473103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC).
    Chotitumnavee J; Yamashita Y; Takahashi Y; Takada Y; Iida T; Oba M; Itoh Y; Suzuki T
    Chem Commun (Camb); 2022 Apr; 58(29):4635-4638. PubMed ID: 35311871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation.
    Márquez-Cantudo L; Ramos A; Coderch C; de Pascual-Teresa B
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROTAC chemical probes for histone deacetylase enzymes.
    Patel U; Smalley JP; Hodgkinson JT
    RSC Chem Biol; 2023 Aug; 4(9):623-634. PubMed ID: 37654508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROTAC-mediated degradation of class I histone deacetylase enzymes in corepressor complexes.
    Smalley JP; Adams GE; Millard CJ; Song Y; Norris JKS; Schwabe JWR; Cowley SM; Hodgkinson JT
    Chem Commun (Camb); 2020 Apr; 56(32):4476-4479. PubMed ID: 32201871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of histone deacetylase 3 (HDAC3)-specific PROTACs.
    Xiao Y; Wang J; Zhao LY; Chen X; Zheng G; Zhang X; Liao D
    Chem Commun (Camb); 2020 Aug; 56(68):9866-9869. PubMed ID: 32840532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of Hydrazide-Based HDAC8 PROTACs for the Treatment of Hematological Malignancies and Solid Tumors.
    Zhao C; Zhang J; Zhou H; Setroikromo R; Poelarends GJ; Dekker FJ
    J Med Chem; 2024 Aug; 67(16):14016-14039. PubMed ID: 39089850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Transcriptomic Analysis of Novel Class I HDAC Proteolysis Targeting Chimeras (PROTACs).
    Baker IM; Smalley JP; Sabat KA; Hodgkinson JT; Cowley SM
    Biochemistry; 2023 Feb; 62(3):645-656. PubMed ID: 35948047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity.
    Darwish S; Ghazy E; Heimburg T; Herp D; Zeyen P; Salem-Altintas R; Ridinger J; Robaa D; Schmidtkunz K; Erdmann F; Schmidt M; Romier C; Jung M; Oehme I; Sippl W
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of highly potent HDAC8 PROTACs with anti-tumor activity.
    Zhao C; Chen D; Suo F; Setroikromo R; Quax WJ; Dekker FJ
    Bioorg Chem; 2023 Jul; 136():106546. PubMed ID: 37098288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROTAC-biomacromolecule conjugates for precise protein degradation in cancer therapy: A review.
    Wang C; Zhang Y; Yu W; Xu J; Xing D
    Int J Biol Macromol; 2024 Mar; 261(Pt 2):129864. PubMed ID: 38302015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance.
    Zhu H; Wang J; Zhang Q; Pan X; Zhang J
    Pharmacol Ther; 2023 Apr; 244():108371. PubMed ID: 36871783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques.
    Chen S; Cui J; Chen H; Yu B; Long S
    Eur J Med Chem; 2023 Dec; 262():115911. PubMed ID: 37924709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.